Hart K C, Xu Y F, Meyer A N, Lee B A, Donoghue D J
Molecular Pathology Program, School of Medicine, University of California, San Diego, La Jolla 92093-0322.
J Cell Biol. 1994 Dec;127(6 Pt 2):1843-57. doi: 10.1083/jcb.127.6.1843.
The location of autocrine interactions between the v-sis protein and PDGF receptors remains uncertain and controversial. To examine whether receptor-ligand interactions can occur intracellularly, we have constructed fusion proteins that anchor v-sis to specific intracellular membranes. Fusion of a cis-Golgi retention signal from a coronavirus E1 glycoprotein to v-sis protein completely abolished its transforming ability when transfected into NIH3T3 cells. Fusion proteins incorporating mutations in this retention signal were not retained within the Golgi complex but instead were transported to the cell surface, resulting in efficient transformation. All chimeric proteins were shown to dimerize properly. Derivatives of some of these constructs were also constructed bearing the cytoplasmic tail from the glycoprotein of vesicular stomatitis virus (VSV-G). These constructs allowed examination of subcellular localization by double-label immunofluorescence, using antibodies that distinguish between the extracellular PDGF-related domain and the VSV-G cytoplasmic tail. Colocalization of sis-E1-G with Golgi markers confirmed its targeting to the early Golgi complex. The sis-E1 constructs, targeted to the early Golgi complex, exhibited no proteolytic processing whereas the mutant forms of sis-E1 exhibited normal proteolytic processing. Treatment with suramin, a polyanionic compound that disrupts ligand/receptor interactions at the cell surface, was able to revert the transformed phenotype induced by the mutant sis-E1 constructs described here. Our results demonstrate that autocrine interactions between the v-sis oncoprotein and PDGF receptors within the early Golgi complex do not result in functional signal transduction. Another v-sis fusion protein was constructed by attaching the transmembrane domain and COOH-terminus of TGN38, a protein that localizes to the trans-Golgi network (TGN). This construct was primarily retained intracellularly, although some of the fusion protein reached the surface. Deletion of the COOH-terminal region of the TGN38 retention signal abrogated the TGN-localization, as evidenced by very prominent cell surface localization, and resulted in increased transforming activity. The behavior of the sis-TGN38 derivatives is discussed within the context of the properties of TGN38 itself, which is known to recycle from the cell surface to the TGN.
v-sis蛋白与血小板衍生生长因子(PDGF)受体之间自分泌相互作用的位置仍不确定且存在争议。为了研究受体-配体相互作用是否能在细胞内发生,我们构建了将v-sis锚定到特定细胞内膜的融合蛋白。将来自冠状病毒E1糖蛋白的顺式高尔基体滞留信号与v-sis蛋白融合,当转染到NIH3T3细胞中时,其转化能力完全丧失。在这个滞留信号中引入突变的融合蛋白没有保留在高尔基体复合物中,而是被转运到细胞表面,从而导致有效的转化。所有嵌合蛋白都显示能正确二聚化。其中一些构建体的衍生物还带有水泡性口炎病毒(VSV-G)糖蛋白的细胞质尾巴。这些构建体使得通过双标记免疫荧光来检查亚细胞定位成为可能,使用能区分细胞外PDGF相关结构域和VSV-G细胞质尾巴的抗体。sis-E1-G与高尔基体标记物的共定位证实了它靶向早期高尔基体复合物。靶向早期高尔基体复合物的sis-E1构建体没有表现出蛋白水解加工,而sis-E1的突变形式表现出正常的蛋白水解加工。用苏拉明处理,一种破坏细胞表面配体/受体相互作用的聚阴离子化合物,能够逆转此处描述的突变sis-E1构建体诱导的转化表型。我们的结果表明,早期高尔基体复合物内v-sis癌蛋白与PDGF受体之间的自分泌相互作用不会导致功能性信号转导。通过连接TGN38(一种定位于反式高尔基体网络(TGN)的蛋白)的跨膜结构域和COOH末端,构建了另一种v-sis融合蛋白。这个构建体主要保留在细胞内,尽管有一些融合蛋白到达了细胞表面。TGN38滞留信号的COOH末端区域的缺失消除了TGN定位,非常明显的细胞表面定位证明了这一点,并导致转化活性增加。在已知从细胞表面循环到TGN的TGN38自身特性的背景下,讨论了sis-TGN38衍生物的行为。